Still Feeling Hungry on Mounjaro? Here's What's Actually Going On

You're on 2.5mg and wondering if it's even doing anything

Picture this: you've had your first pen of Mounjaro, you've done everything right, and by day four you're eating a full lunch and still thinking about biscuits by three o'clock. This is one of the questions our prescribers hear most weeks, and the answer is almost always the same, the starter dose isn't the treatment dose.

The 2.5mg dose exists primarily to give your digestive system time to adapt. It reduces the risk of nausea and vomiting during the early weeks, not to deliver the appetite suppression that's described in clinical trials. Most of the evidence for tirzepatide's effect on hunger and weight comes from higher doses: in the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants lost around 20–21% of body weight on average at 15mg over 72 weeks. That kind of outcome reflects months of titration, not the first four weeks. So if your hunger hasn't changed much yet, that experience is entirely consistent with where you are in the process.

Appetite suppression typically becomes more noticeable after the first or second dose increase. Some people feel a clear shift at 5mg; others notice it more at 7.5mg. The trajectory is individual, and it's worth tracking rather than drawing conclusions too early.

The day-six hunger window, and why it's not a red flag

Many people on tirzepatide notice a particular pattern: appetite feels well-managed around days two to four after an injection, then creeps back in the final couple of days before the next one. This is sometimes called the end-of-week dip, and it's worth understanding rather than worrying about.

Tirzepatide is given once weekly, and blood levels naturally taper toward the end of each dosing interval. That dip in concentration can be enough to let some appetite signals return. It doesn't mean the medicine has stopped working, it means you're noticing its pharmacology. The reasons hunger returns toward injection day are well-documented, and the pattern often becomes less pronounced as your dose increases.

If the final-day hunger is significant enough to be driving overeating, that's worth raising with your prescriber. Timing your injection consistently each week (same day, ideally the same time) helps maintain steadier levels. There's also evidence from NHS guidance on tirzepatide that what and when you eat can meaningfully influence how well the medicine's gastric-slowing effect supports fullness throughout the week.

What to eat on Mounjaro to make hunger easier to manage

One misconception worth gently letting go of: that eating less automatically means eating right on Mounjaro. Tirzepatide does reduce how much most people want to eat, but smaller portions of low-protein, quickly digested food can leave you genuinely hungry again within a couple of hours, even when the medicine is working well.

Tirzepatide slows gastric emptying, which means food stays in your stomach longer. Foods that extend that effect usefully are protein-rich (eggs, fish, Greek yoghurt, legumes, chicken) and fibre-dense (vegetables, oats, lentils, wholegrains). These sit in the stomach longer naturally, work with the medicine's mechanism, and support steadier blood sugar. You can read about which foods tend to work best alongside tirzepatide in more detail, including practical meal ideas.

Hydration matters too. Thirst and hunger signals can overlap, and mild dehydration is more likely on GLP-1 treatments if nausea is reducing your fluid intake. Aiming for consistent water intake through the day (before you feel thirsty) is one of the simplest practical steps.

One note on specific foods: some higher-fat items slow gastric emptying so much they can cause uncomfortable fullness or nausea. If you're curious about foods like cheese, which affect some people this way, that's worth knowing before you assume hunger is the only challenge you'll face with eating on Mounjaro.

When to talk to your prescriber about persistent hunger

Hunger that makes it genuinely difficult to follow a reduced-calorie pattern (or that hasn't shifted at all after two or three dose increases) is worth a clinical conversation. This isn't about pushing for faster titration; it's about making sure your treatment is being managed properly at each stage.

At nume, every repeat order is reviewed by a GPhC-registered prescriber before it's approved. That review is the right moment to raise appetite concerns, because dose decisions should always sit with a clinician who knows your full picture. If you're on a dose that's no longer challenging you and you haven't had a clinical review, that's the gap to close.

For a broader look at how tirzepatide works and what to expect at different stages, the Mounjaro treatment overview covers the full picture. And if you're still weighing up what treatment might suit you, a free consultation with our prescribers is the practical next step, no commitment, no algorithm, just a clinician reading your information the same day. It's also worth knowing that Mounjaro's UK pricing has changed over the past year, so understanding the full cost is part of planning treatment sensibly.